Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength
Open Access
- 23 November 2015
- journal article
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 49 (1) , 35-44
Abstract
We investigated the associations of sarcopenia-defined both in terms of muscle mass and muscle strength-and sarcopenic obesity with metabolic syndrome. Secondary data pertaining to 309 subjects (85 men and 224 women) were collected from participants in exercise programs at a health center in a suburban area. Muscle mass was measured using bioelectrical impedance analysis, and muscle strength was measured via handgrip strength. Sarcopenia based on muscle mass alone was defined as a weight-adjusted skeletal muscle mass index more than two standard deviations below the mean of a sex-specific young reference group (class II sarcopenia). Two cut-off values for low handgrip strength were used: the first criteria were <26 kg for men and <18 kg for women, and the second criteria were the lowest quintile of handgrip strength among the study subjects. Sarcopenic obesity was defined as the combination of class II sarcopenia and being in the two highest quintiles of total body fat percentage among the subjects. The associations of sarcopenia and sarcopenic obesity with metabolic syndrome were evaluated using logistic regression models. The age-adjusted risk ratios (RRs) of metabolic syndrome being compared in people with or without sarcopenia defined in terms of muscle mass were 1.25 (95% confidence interval [CI], 1.06 to 1.47, p=0.008) in men and 1.12 (95% CI, 1.06 to 1.19, p<0.001) in women, which were found to be statistically significant relationships. The RRs of metabolic syndrome being compared in people with or without sarcopenic obesity were 1.31 in men (95% CI, 1.10 to 1.56, p=0.003) and 1.17 in women (95% CI, 1.10 to 1.25, p<0.001), which were likewise found to be statistically significant relationships. The associations of sarcopenia defined in terms of muscle mass and sarcopenic obesity with metabolic syndrome were statistically significant in both men and women. Therefore, sarcopenia and sarcopenic obesity must be considered as part of the community-based management of non-communicable diseases.Keywords
Funding Information
- Chung-Ang University
This publication has 39 references indexed in Scilit:
- Clinical and Physiopathological Mechanism of SarcopeniaThe Korean Journal of Medicine, 2012
- Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey IIIPLOS ONE, 2010
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Sarcopenic obesity: definition, cause and consequencesCurrent Opinion in Clinical Nutrition and Metabolic Care, 2008
- Nutritional Supplements with Oral Amino Acid Mixtures Increases Whole-Body Lean Mass and Insulin Sensitivity in Elderly Subjects with SarcopeniaThe American Journal of Cardiology, 2008
- A Geospatial Analysis of Emergency Transport and Inter-Hospital Transfer in ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2008
- Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort StudyQJM: An International Journal of Medicine, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly womenInternational Journal of Obesity, 2004
- Catabolism of aging: is it an inflammatory process?Current Opinion in Clinical Nutrition and Metabolic Care, 2003